Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Type 2 diabetes and treatment intensification in primary care in Finland.
Niskanen L, Hahl J, Haukka J, Leppä E, Miettinen T, Mushnikov V, Sipilä R, Tamminen N, Vattulainen P, Korhonen P. Niskanen L, et al. Among authors: hahl j. Acta Diabetol. 2018 Nov;55(11):1171-1179. doi: 10.1007/s00592-018-1199-7. Epub 2018 Aug 6. Acta Diabetol. 2018. PMID: 30083982
Uses of Electronic Patient Information Systems and National Registers - Implementation of the Clinical Practice Guideline and Evaluation of Costs and Use of Resources in Patients with Incident Type 2 Diabetes in Finland.
Prami T, Sulamaa A, Sipilä R, Linna M, Hahl J, Miettinen T, Leppä E, Haukka J, Tuomilehto J, Enlund H, Niskanen L, Korhonen P. Prami T, et al. Among authors: hahl j. Value Health. 2014 Nov;17(7):A336. doi: 10.1016/j.jval.2014.08.649. Epub 2014 Oct 26. Value Health. 2014. PMID: 27200599 Free article. No abstract available.
Costs of predicting IDDM.
Hahl J, Simell T, Ilonen J, Knip M, Simell O. Hahl J, et al. Diabetologia. 1998 Jan;41(1):79-85. doi: 10.1007/s001250050870. Diabetologia. 1998. PMID: 9498634 Clinical Trial.
Costs of insulin-dependent diabetes mellitus.
Simell TT, Sintonen H, Hahl J, Simell OG. Simell TT, et al. Among authors: hahl j. Pharmacoeconomics. 1996 Jan;9(1):24-38. doi: 10.2165/00019053-199609010-00004. Pharmacoeconomics. 1996. PMID: 10160085 Review.
16 results